title: Effects of long-term ingestion of aspartame on hypothalamic neuropeptide Y, plasma leptin and body weight gain and composition.
abstract: The aim of this study was to determine the effects of the chronic ingestion of aspartame (ASP) on brain neuropeptide Y (NPY) concentrations, plasma hormones, food intake and body fat. Two groups of male Long-Evans rats, fed on a control (C) well-balanced diet, had to drink either a 0.1% ASP solution or water for a period of 14 weeks starting at weaning. Food intake and body weight were weekly recorded. At the end of the experiment, fat pads were sampled, leptin and insulin were measured in the plasma and NPY in several microdissected brain areas. Substituting ASP for water led to lower body weight (-8%; P<.004) and lower fat depot weight (-20%; P<.01) with no differences in energy intake or plasma insulin concentrations. Plasma leptin was significantly reduced by 34% (P<.05). Leptin concentrations were well-correlated with final body weight (r=.47; P<.025) and fat pad mass (r=.53; P<.01). NPY concentrations were 23% lower (P<.03) in the arcuate nucleus of ASP rats with no differences in other brain areas. The beneficial effects on body composition could be related to the decreased effects of NPY on lipid and energy metabolism, independently of insulin. The reasons for the NPY decrease (regulatory or toxicological) are not obvious. The constitutive amino acids of the ASP molecule might participate in the NPY regulation.
authors.affiliation: Centre de Recherches UHP/EA 3453, IFR no. 111, Systèmes Neuromodulateurs des Comportements Ingestifs; 38, rue Lionnois, 54000 Nancy, France. bernard.beck@nancy.inserm.fr
authors.forename: Bernard
authors.initials: B
authors.lastname: Beck
authors.forename: Arlette
authors.initials: A
authors.lastname: Burlet
authors.forename: Jean Pierre
authors.initials: JP
authors.lastname: Max
authors.forename: Alain
authors.initials: A
authors.lastname: Stricker-Krongrad
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects / Q000254:growth & development; D000818:Animals; D001218:Aspartame / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D001823:Body Composition / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D004734:Energy Metabolism / Q000187:drug effects; D006128:Growth / Q000187:drug effects; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D020738:Leptin / Q000097:blood*; D008297:Male; D009478:Neuropeptide Y / Q000378:metabolism*; D051381:Rats; D020318:Rats, Long-Evans; D013549:Sweetening Agents / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D020738:Leptin; D009478:Neuropeptide Y; D013549:Sweetening Agents; D001218:Aspartame